• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

    Oleic Acid Possibly Implicated in MS Pathology

    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet

    Gadot Positions Mineral Line for Vegan Market

    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

    Oleic Acid Possibly Implicated in MS Pathology

    Herbal Suppliers Discuss the Impact of COVID-19 on Sustainable Supply Chains

    Gadot Positions Mineral Line for Vegan Market

    FrieslandCampina Launches Biotis Immune Health Ingredient
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

    Oleic Acid Possibly Implicated in MS Pathology

    Herbal Suppliers Discuss the Impact of COVID-19 on Sustainable Supply Chains

    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet

    Gadot Positions Mineral Line for Vegan Market
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

    Oleic Acid Possibly Implicated in MS Pathology

    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet

    FrieslandCampina Launches Biotis Immune Health Ingredient

    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Vesta Nutra

    Verdure Sciences

    Indena USA, Inc.

    Bioenergy Life Science, Inc. (BLS)

    AIDP
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Verdure Sciences

    Vesta Nutra

    Sabinsa Corporation

    Aiya America (Matcha by Aiya)

    Chenland Nutritionals Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Oral Solids Remain Robust

    Exploring trends in the oral solid dosage manufacturing market with some of today’s leading contract service providers.

    Oral Solids Remain Robust
    Oral solid dosage forms continue to be the preferred route of administration.
    By Tim Wright , Editor, Contract Pharma03.02.20
    Oral solids continue to represent by far the largest category of pharmaceuticals manufactured today. With billions and billions of capsules and tablets produced annually worldwide, today’s oral solid dose (OSD) market remains robust.

    Despite the rise in biologics, oral solid dosage forms continue to be the preferred route of administration due to their cost-effectiveness, relative ease of manufacturing, and patient-friendly dose form options.

    In fact, the small molecule outsourcing market is expected to reach $69.4 billion by 2024, with the demand being driven by complex molecules, according to Visiongain’s report, “Pharmaceutical Contract Manufacturing Market 2019-2029.”

    “The oral solid dose development and manufacturing market is a mature market that continues to be a growing space,” said Ania VanDyke, associate director of business development, contract manufacturing, AbbVie. “Oral solid dose products are a preferred option due to convenience and improved patient compliance. However, as there is an increase in challenging and difficult to manufacture molecules in the developmental space, formulation and manufacturing of oral solid dosage forms is becoming more complex.”

    The market is robust as the pipeline of oral solid dose products in development is strong and continues to grow, according to Terence Novak, chief operating officer, Tedor Pharma, especially with the small to mid-size companies that have products in development and are looking for clinical trial supply or development expertise.

    “These companies have little to no production infrastructure and need quality contract development and manufacturing organization (CDMO) services,” he said. “In 2018, NDA approvals for tablets and capsules outstripped approvals for injectables, a notable shift in the market, and companies continue to look to develop products that are more convenient for patients. There has also been a fair number of generic companies looking for additional manufacturing capacity.”

    Smaller Batches, Higher Potency
    A number of trends are having an impact on today’s OSD market, which is and will continue to be dominated by small- and medium-sized sponsor companies. One is a growing emphasis on smaller batch sizes, according to John Ross, president, Mayne Pharma USA. “With drug sponsors, distributors and patients demanding more flexibility regarding cost, access and cycle times—and blockbuster drugs losing patent protections—the entire industry is moving toward smaller batch processing,” he said. “Another trend is the extensive demand for high-potency API (HPAPI) handling. The HPAPI market is expected to increase to $27 billion by 2023, representing a 63% jump from 2016.”

    Yet a third driver involves supply expectations from global consumers. “While sales in North America and Western Europe account for about 55% of the world’s pharmaceutical market, the Asia Pacific market is growing substantially, fueled by improved access to medicines,” said Ross. “This challenges pharma companies when it comes to building global supply chains that are cost-effective and flexible.”

    According to Angela Hoffnagle, product manager Rx oral dose, Catalent, advancements in drug delivery technologies for modified-release dosage forms, molecules requiring bioavailability enhancement, and the growth in highly potent compounds are significant influences on this market’s continued growth.

    “Due to the number of poorly soluble and complex compounds in the pharmaceutical industry’s pipeline, there has been an increase in demand for bioavailability-enhancing technologies such as spray drying and hot melt extrusion (HME),” she said. “We are also seeing an increase in demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery forms. This is in part driven by an increase in oncology treatments that are commonly of greater potency.”

    Also addressing the solubility issue, AbbVie’s VanDyke said as many as 70% of New Chemical Entities (NCEs) have poor solubility and/or bioavailability. “As a result, we are seeing an increased demand for technologies such as HME to aid in improving solubility and enhancing bioavailability,” she said. “Products are also targeting more specific indications with smaller patient populations requiring smaller manufacturing scales. In addition, there is an increase in potent molecules particularly in the growing oncology space.”

    Lean Mean Machine
    In addition to HPAPI handling and enhanced capacity to offer solubility and bioavailability solutions already discussed, another key opportunity for growth exists in lean manufacturing pursuits for both, according to Ross. The capital investments required to successfully offer HPAPI handling and solubility and bioavailability solutions are significant.

    “While the ideal of lean manufacturing is a challenge for any industry, this has been especially true for pharma, which traditionally has experienced high profit margins and carried large inventories as insurance against unreliable supply chains,” he said. “Latent inefficiency has been ‘affordable’ when compared to the profit margins of a drug product. Those days are gone, however. Now, optimizing manufacturing operations enables the ROI of more capital-intensive operations to be attainable and the cost-of-goods to be reasonable.”

    Novak agreed that lean processes are the way forward. “Lean and more efficient manufacturing processes are other opportunities for growth as, given the smaller batch sizes, changeover will be important in order to serve more customers and diversify CDMO portfolios,” he said.

    In addition, Novak said vertical integration to add select capabilities that can best serve the companies from development through commercialization is important in today’s market.

    Catalent’s Hoffnagle concurred. According to her, the need for end-to-end solutions, from drug discovery to screening, scale-up from early development to clinical trials, and on to commercial manufacturing, and packaging, continues to be a major driver across the pharma outsourcing landscape.

    “As an outsourcing partner that is involved in a project from the early-development phase through to scale-up and commercial manufacturing, we can increase the likelihood for a program’s success through an intimate understanding of the project’s milestones and interplay between each phase along the product’s development and manufacturing journey,” she said. “This allows for a strategic, long-term partnership, where both parties understand the important project requirements, while keeping the patient in mind at every stage.”

    Solving Solubility Issues
    Today’s leading contract service providers are continuously developing new technology solutions to overcome formulation and manufacturing challenges.

    “As newly identified APIs increasingly prove to be less soluble or poorly bioavailable, reliance upon solutions such as fluid bed and spray drying will increase,” said Ross. “Likewise, dry granulation processing continues to trend upward.”

    He said mini-tablets are emerging as an advantageous approach to treating pediatric and geriatric patients because of their inherently flexible dosing capability.

    There is also growth potential in the development and manufacturing of amorphous solid dispersions (ASD) utilizing HME, according to  VanDyke, who said this an effective way to improve solubility and/or bioavailability for BCS class II and IV APIs. While not a new technology for many other industries, extrusion is newer to the pharmaceutical industry and can be used to manufacture ASDs as well as to replace batch granulation processes.

    “ASD offers a solution to the 70% of NCEs today that are poorly soluble and/or bioavailable,” she said. “Rationally designed ASDs can achieve higher apparent solubility and improved bioavailability while HME is an effective enabling technology to manufacture ASDs. During the HME process, a powder blend consisting of crystalline API and polymer(s) is transformed into an extrudate, which contains molecularly dispersed amorphous API in a polymer matrix. The extrudate is subsequently converted into granules or pellets for downstream processing using standard oral solid dose equipment. The extrusion process can also replace batch granulation processes as a continuous melt or wet granulation process. Compared to a traditional batch process, this exciting yet complex technology offers many advantages including but not limited to excellent product uniformity and higher manufacturing efficiency.”

    When developing poorly soluble drugs as oral solid dosage forms, Hoffnagle said companies are sometimes not sufficiently rigorous in identifying future potential problems with their molecules. “There are various technologies to solubilize poorly soluble drugs, but the real challenge is to pick the most suitable technology for the molecule throughout its development journey,” she said. “Each technology is best suited to molecules with certain characteristics, so consideration should be given to the product’s physicochemical properties, drug targets and absorption sites, dose, and pharmacokinetic (PK) characteristics, among others. When patient-centric drug product design is considered, this adds another level of complexity. For example, manufacturing a pediatric oral solid dosage form with taste-masking properties and the flexibility for dose titration and administration across the pediatric age groups is probably one of the biggest challenges in drug development.”

    Another area that is seeing greater demand is for instrumented technologies to enable deeper process understanding and facilitate continuous process validation. Data analytics coupled with machine learning or deep learning is an upcoming field of interest in the pharmaceutical drug development community.

    “Deep learning methods have recently demonstrated to be able to predict the in vivo and in vitro characteristics based on the formulation and process data,” said Hoffnagle. “As we continue to develop a better understanding of deep learning methods within the pharmaceutical domain, it is foreseen that it will be a key technology driving pharmaceutical experimental design that will support and control product quality in the entire product development cycle.”

    Moving forward OSD drug developers and manufacturers face some clear challenges ahead. One is delivering competitive cost of goods related to small-batch production, according to Ross. “Batch fixed costs make up a significant proportion of overall drug product cost—typically greater than 50%,” he said. “This is commercially prohibitive for small batches and will require manufacturers to reconsider long-established practices in order to reduce fixed costs.”

    He also said accommodating to the varied expectations of sponsors and diverse global markets in a cost-effective manner is another challenge facing OSD manufacturers.

    Customers who have utilized CDMOs to develop formulations and processes for their poorly soluble APIs are not always optimal, according to VanDyke. This makes technical transfers into facilities challenging and often requires reformulation work.

    “When a formulation and process design is flawed, it can cause many challenges downstream, such as the need to repeat clinical studies, stability failures, and manufacturing challenges that can impact drug product supply,” she said. “It is therefore critical to establish a robust formulation upfront to minimize loss of time and increased costs.” 
    Related Searches
    • Delivery
    • equipment
    • Contract Manufacturing
    • Dosage
    Related Knowledge Center
    • Contract Manufacturing
    • Delivery & Dosage Technologies

    Related Features

    • Antioxidants | Contract Manufacturing | Fiber & Carbohydrates | Herbs & Botanicals | Marine Nutraceuticals | Minerals | Omega-3s | Probiotics & Prebiotics | Proteins, Peptides, Amino Acids | Vitamins
      2021 International Buyers

      2021 International Buyers' Guide

      An annual reference of companies supplying nutraceutical ingredients, products, and services around the world.
      Compiled by Nutraceuticals World Staff 12.04.20

    • Delivery & Dosage Technologies | Herbs & Botanicals
      CBD Formulations That Meet Consumer Demands: Opportunities & Challenges

      CBD Formulations That Meet Consumer Demands: Opportunities & Challenges

      No matter the application, it’s critical to begin with raw materials that have been thoroughly tested and validated for quality.
      By Collette Kakuk, Vice President of Global Marketing, Layn Natural Ingredients & HempRise 11.02.20

    • Cosmeceuticals / Nutricosmetics | Delivery & Dosage Technologies | Herbs & Botanicals
      Keys to Nourishing CBD Skin Care Growth

      Keys to Nourishing CBD Skin Care Growth

      Improving ingredient delivery through carrier oils can go a long way to meeting consumer demand for product performance.
      By John Toner & Diva Chan, Aprinnova 11.02.20


    • Delivery & Dosage Technologies | Immune Function | Minerals | Vitamins
      Key Immune Health Ingredients & A Unique Delivery System

      Key Immune Health Ingredients & A Unique Delivery System

      Oral Thin Film Strip Melts work particularly well with popular ingredients like vitamins D3, K2, and zinc.
      By John G. Tobin, President/CEO NutraFood Science Delivery System, Inc. 10.01.20

    • Delivery & Dosage Technologies | Dietary Supplements | Immune Function | Minerals | Products | Vitamins
      Nature Made Launches ImmuneMax Fizzy Drink Mix

      Nature Made Launches ImmuneMax Fizzy Drink Mix

      Powdered drink mix delivers 2,000 mg of vitamin C, 25 mcg of vitamin D, and 20 mg of zinc per stick pack.
      By Sean Moloughney, Editor 10.01.20

    • Delivery & Dosage Technologies | Dietary Supplements | Green Foods | Healthcare Trends
      The Future’s Looking Green

      The Future’s Looking Green

      Green foods are a well-rooted market segment, whose water-based sources promise plenty of new opportunities.
      By Mike Montemarano, Associate Editor 09.08.20


    • Delivery & Dosage Technologies | Digestive Health | Infant & Children's Health | Probiotics & Prebiotics | Research
      New Potential for Human Milk Oligosaccharides

      New Potential for Human Milk Oligosaccharides

      HMOs boost the immune system and protect against infections.
      By Ellen Kilger, PhD, Contributing Writer 06.02.20

    • Consumer Trends | Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Mood Health & Sleep
      New Chapter Debuts Line of Once-Daily Botanical Blends

      New Chapter Debuts Line of Once-Daily Botanical Blends

      The latest installment from the nearly 50-year-old herbal products company features solutions to support stress, sleep, and holistic well-being.
      By Mike Montemarano, Associate Editor 06.02.20

    • Cosmeceuticals / Nutricosmetics | Delivery & Dosage Technologies | Herbs & Botanicals | Research
      CBD in Skin Care

      CBD in Skin Care

      Two types of cannabinoid receptors have been identified in human cells. Keratinocytes contain both, justifying interest in CBD among cosmetic companies.
      By Paolo U Giacomoni, PhD, Insight Analysis Consulting 04.02.20


    • Contract Manufacturing | Dietary Supplements | Quality & Safety | Testing
      The True Cost of Quality

      The True Cost of Quality

      Supplier partnerships are an extension of brands, and have real world implications for your reputation.
      By John Davidson, Deerland Probiotics & Enzymes 03.02.20

    • Contract Manufacturing | Dietary Supplements | Quality & Safety
      2020 Contract Manufacturing Survey

      2020 Contract Manufacturing Survey

      Now in its third year, our audience poll offers insights on why brands outsource manufacturing and what they look for.
      By Sean Moloughney, Editor, Nutraceuticals World 03.02.20

    • Contract Manufacturing | Dietary Supplements | Quality & Safety | Regulations | Testing
      Avoiding Contract Manufacturing Pitfalls in the Dietary Supplement Market

      Avoiding Contract Manufacturing Pitfalls in the Dietary Supplement Market

      A recent product recall shines a spotlight on the marketer/manufacturer relationship.
      By Sean Moloughney, Editor, Nutraceuticals World 03.02.20


    • Contract Manufacturing
      Manufacturing Equipment Technology

      Manufacturing Equipment Technology

      The future of highly compliant, efficient equipment that’s customized to suit a large variety of applications.
      By Kristin Brooks, Managing Editor, Contract Pharma 03.02.20

    • Consumer Trends | Delivery & Dosage Technologies | Fiber & Carbohydrates | Minerals | Proteins, Peptides, Amino Acids | Vitamins
      The Rise of Good-For-You Gummies

      The Rise of Good-For-You Gummies

      Amid growing market opportunities, formulators have next generation solutions to overcome manufacturing challenges.
      By Lara Niemann, Global Marketing, GELITA 01.07.20

    • Bone & Joint Health | Cognitive Function | Delivery & Dosage Technologies | Dietary Supplements | Energy | Functional Foods & Beverages | Healthy Aging | Herbs & Botanicals | Marine Nutraceuticals | Proteins, Peptides, Amino Acids | Sports Nutrition | Vitamins
      Taking Aim at a Healthy Sports Nutrition Market

      Taking Aim at a Healthy Sports Nutrition Market

      Varied product solutions help consumers meet personal performance goals.
      By Sean Moloughney, Editor 11.05.19

    Trending
    • Nutrition Industry Reacts To 2020-2025 Dietary Guidelines For Americans
    • Preliminary Study Suggests Link Between Omega-3s And Lower COVID-19 Death Rates
    • Maternal Dietary Intake Of Fish, Omega-3s, And Omega-6s Linked To Child Neurodevelopment
    • Mintel Announces Global Food And Drinks Trends For 2021
    • Gadot Positions Mineral Line For Vegan Market
    Breaking News
    • Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    • Oleic Acid Possibly Implicated in MS Pathology
    • NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet
    • Gadot Positions Mineral Line for Vegan Market
    • Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    Oleic Acid Possibly Implicated in MS Pathology
    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet
    Coatings World

    Latest Breaking News From Coatings World

    APV Engineered Coatings Reflects on 2020
    LINE-X Launches Dealer Program with International Truck
    BCF CEO to Chair Royal Society of Chemistry Surface Coatings Interest Group
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Alleviant's Transcatheter Tech Obtains Breakthrough Status
    Signia Appoints New President
    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Humanigen, Emergent Enter Covid-19 Partnership
    Samsung Bioepis Opens New Headquarters
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fitglow Beauty Wins Big at Annual Dirty Thinker’s Choice Awards
    e.l.f. Cosmetics Unveils Mint Melt Collection
    Estée Lauder Companies Updates Supply Chain Leadership
    Happi

    Latest Breaking News From Happi

    Wellness Brand Partners with Kate Upton
    Some Good News at Inter Parfums
    Professional Beauty Association Names New Executive Director
    Ink World

    Latest Breaking News From Ink World

    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    VPF launches deep-freeze adhesive
    ProMach strengthens flexible packaging business
    Gallus planning virtual event for March
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Patient Implanted With NEXXT MATRIXX SA Cervical Turn-Lock System
    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    Imec Technology Taking Off to Space
    North American Semiconductor Equipment Industry Posts December 2020 Billings

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login